F11R and breast carcinoma: Finally, using ex vivo immunoprecipitation (IP) strategies in primary cultures generated from patients with breast cancer, we demonstrate that the JAM-A signalling complexes identified in vitro in MCF7 cells also exist in tissues of patients with breast cancer.